Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
Search or
𝛼
SK
SIGN UP
SIGN IN
ENTITY
3SBio Inc (1530 HK)
Watchlist
151
Analysis
Health Care
•
China
3SBio, Inc. is a biotechnology company located in China. The Company focuses on mammalian cell-based biopharmaceuticals in the biotechnology industry. 3SBio also develops, manufactures and markets biopharmaceutical products globally.
more
Watchlist
All
Insights
Primers
New
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Shanghai Henlius Biotech
•
30 Jan 2019 10:22
Shanghai Henlius (复宏汉霖) IPO: Not an Impressive Biosimilar Portfolio
Shanghai Henlius, a subsidiary of Fosun Pharma, is seeking to list in Hong Kong. In this insight, we will discuss the following topics: The...
Ke Yan, CFA, FRM
Follow
1.3k Views
Share
bullish
•
CRRC Corp Ltd H
•
28 Jan 2019 15:45
HK Connect Discovery Weekly: CRRC, Car Inc/UCar (2019-01-25)
In our Discover HK Connect series, we aim to help our investors understand the flow of southbound trades via the Hong Kong Connect, as analyzed by...
Ke Yan, CFA, FRM
Follow
600 Views
Share
bullish
•
Great Wall Motor
•
09 Jan 2019 09:55
HK Connect Discovery Weekly: CR Beer, Great Wall Motors, and Kingsoft (2019-01-07)
In our Discover HK Connect series, we aim to help our investors understand the flow of southbound trades via the Hong Kong Connect, as analyzed by...
Ke Yan, CFA, FRM
Follow
784 Views
Share
bullish
•
Yichang HEC Changjiang Pharma
•
02 Jan 2019 15:09
Discover HK Connect: Mainlanders Were Buying Pharma and Property Managers in December
In our Discover HK Connect series, we aim to help our investors understand the flow of southbound trades via the Hong Kong Connect, as analyzed by...
Ke Yan, CFA, FRM
Follow
756 Views
Share
bullish
•
Tingyi Holding
•
10 Dec 2018 09:10
Discover HK Connect: Mainlanders Are Buying Shandong Gold, Tingyi, YiChang HEC (2018-12-10)
In our Discover HK Connect series, we will help our investors understand the flow of southbound trades via the Hong Kong Connect, as analyzed by...
Ke Yan, CFA, FRM
Follow
433 Views
Share
First
Previous
21
22
23
24
25
26
27
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.59.7
x